Allmed Solutions Ltd - Asset Resilience Ratio
Allmed Solutions Ltd (ALMD) has an Asset Resilience Ratio of 80.03% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Allmed Solutions Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2008–2025)
This chart shows how Allmed Solutions Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Allmed Solutions Ltd (ALMD) total assets.
Liquid Assets Composition Over Time
This chart breaks down Allmed Solutions Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Allmed Solutions Ltd (ALMD) financial obligations for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 0% |
| Short-term Investments | ILA25.25 Million | 80.03% |
| Total Liquid Assets | ILA25.25 Million | 80.03% |
Asset Resilience Insights
- Very High Liquidity: Allmed Solutions Ltd maintains exceptional liquid asset reserves at 80.03% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Allmed Solutions Ltd Industry Peers by Asset Resilience Ratio
Compare Allmed Solutions Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
TransMedics Group Inc
NASDAQ:TMDX |
Medical Devices | 0.00% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581 |
Medical Devices | 18.80% |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580 |
Medical Devices | 10.74% |
|
Nanjing Medlander Medical Technology Co. Ltd. A
SHG:688273 |
Medical Devices | 34.29% |
Annual Asset Resilience Ratio for Allmed Solutions Ltd (2008–2025)
The table below shows the annual Asset Resilience Ratio data for Allmed Solutions Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 80.03% | ILA25.25 Million ≈ $67.68K |
ILA31.54 Million ≈ $84.57K |
-7.63pp |
| 2024-12-31 | 87.66% | ILA39.27 Million ≈ $105.27K |
ILA44.79 Million ≈ $120.09K |
+2.44pp |
| 2023-12-31 | 85.22% | ILA50.43 Million ≈ $135.19K |
ILA59.17 Million ≈ $158.63K |
+77.27pp |
| 2019-12-31 | 7.96% | ILA5.35 Million ≈ $14.34K |
ILA67.20 Million ≈ $180.17K |
-12.94pp |
| 2018-12-31 | 20.89% | ILA9.00 Million ≈ $24.14K |
ILA43.09 Million ≈ $115.52K |
-8.06pp |
| 2017-12-31 | 28.95% | ILA15.01 Million ≈ $40.24K |
ILA51.85 Million ≈ $139.02K |
+7.87pp |
| 2016-12-31 | 21.08% | ILA11.01 Million ≈ $29.51K |
ILA52.22 Million ≈ $140.00K |
-15.81pp |
| 2015-12-31 | 36.88% | ILA21.01 Million ≈ $56.32K |
ILA56.95 Million ≈ $152.69K |
+28.78pp |
| 2012-12-31 | 8.10% | ILA6.52 Million ≈ $17.49K |
ILA80.52 Million ≈ $215.88K |
+7.76pp |
| 2011-12-31 | 0.34% | ILA270.00K ≈ $723.86 |
ILA79.55 Million ≈ $213.28K |
-20.63pp |
| 2008-12-31 | 20.96% | ILA3.25 Million ≈ $8.70K |
ILA15.48 Million ≈ $41.51K |
-- |
About Allmed Solutions Ltd
Allmed Solutions Ltd develops, manufactures, and markets minimally invasive products in various medical disciplines in Israel and internationally. The company offers drugs, biological products, and medical devices; and ProCatid system, a distal embolic protection system comprised of an independent filter unit that can be delivered, locked, and deployed on any commercially marketed guide wires. It… Read more